Baxter has been obliterated on the back of Ozempic. This stocks is hitting multidecade support, in a very oversold condition on the larger time frames. You also have a Monthly RSI divergence occurring which could help the technical bounce scenario .
Eli Lilly has completed 3 red weeks in a row. The parabolic rise it is seeing for years is seen accurately on this Fibonacci Channel. Every such price peak, pulled back to under the MA100 (1d), which is now at 492.43, in order to gather buyers. Trading Plan: 1. Sell on the current market price. Targets: 1. 490 (between the MA100 (1d) and the Fibonacci 2.0...
Eli Lilly has seen enormous growth over the past few years and in particularly in 2023. This Channel Up on the log chart's 1W timeframe is the best depiction of the long term trend. The 1W outlook got extremely overbought technically three weeks ago (RSI = 68.989, MACD = 46.590, ADX = 60.019) and is now correcting. The rejection took place at the top of the...
Hello There! Welcome to my new analysis about LLY on several timeframe perspectives. LLY printed an major bullish breakout literally over night bouncing out of the range. In the recent times the pharma industry transformed into a eager bullish environment since the gains seen because of the "pandemic" and LLY is a stock already present since 1978 in the 19th...
HealthCare looks to have just closed the week with a failed breakout. Getting a weekly close below the impulse breakout green canceled is never a good sign. Off of Bearish consolidation some Health care stocks may be a good short play. Using the up-sloping trend line & weekly 200 MA as support. Using the Weekly 100 MA as resistance . Recapturing the Weekly...
Earlier this year we gave a strong buy signal on Eli Lilly and Company (LLY) on March 01 (see chart below) where we called for the most optimal buy entry exactly at the bottom of the bullish pattern: The price has now hit (last week) the top of the 4 year logarithmic Channel Up, highly overbought with the RSI on the 1W time-frame reaching 84.30, breaking...
Last time we looked at Eli Lilly and Company (LLY) was on March 01 (see chart below) where we called for the most optimal buy entry exactly at the bottom of the bullish pattern: The price is now approaching the top of the 3 year logarithmic Channel Up, highly overbought with the RSI on the 1W time-frame at 80.00. This gradually calls for a sell towards the...
My analysis is on the 2H. I am uniquely qualified in my fundamental analysis. This is a one day until earnings. My thesis is the earnings will stimulate what will be a breakout from a flat bottom triangle. I will buy one share of stock. I will spend a similar amount on call options striking $460 expiring August 11th. I see LLY as surging while PFE is a bit...
Analyzing the options chain and the chart patterns of LLY Eli Lilly prior to the earnings report this week, I would consider purchasing the 450usd strike price Calls with an expiration date of 2023-8-11, for a premium of approximately $11.70. If these options prove to be profitable prior to the earnings release, I would sell at least half of them. Looking forward...
XLV health care has had a tremendous rally as money has moved into these defensive business models. LLY looks primed for a decent pullback .
LLY missed out on earnings while being near it's all-time high. Technical analysis indicates a bearish sentiment as the chart forms a rising wedge. Bearish divergence on the MACD chart. Entry price at 392.90 Exit price at 369.56 Stop loss at 401.7
PFE just raised its dividend On the chart it has been trending downward as shown also by a down sloping anchored VWAP bands. Price is currently sitting at long term support and two standard deviations below VWAP. It appears to be ready to reverse from the deep undervalued area. In confirmation, teh voume indicator shows moderate increased...
- LLY is in a rising trend channel in the medium long term. - LLY has also received a positive signal from the moving average indicator, thus signaling a continued rise. - LLY has broken up through resistance at 375. - The short term momentum of the stock is strongly positive, with RSI above 70. - Overall assessed as technically positive for the medium long...
LLY is WAY overbought here and for a short term scalp we should revisit in next few days $355.96 and $347.21 before possibly breaking out to an all time high as this stock has been in a forever uptrend
LLY has a good bull trend channel on a day time frame RSI at the moment at 368 is overbought and there might be correction where it will stay in accumulation mode or flat line for some time but then it can continue to move forward . should be bought with those opportunities
Eli Lilly and Company (LLY) has been trading within a Channel Up pattern since the October 30 2020 low exactly on the 1W MA100 (red trend-line). As the 1D RSI turned oversold below the 30.00 barrier, while the price touched the bottom (Higher Lows trend-line) of the Channel Up, it has filled all conditions for the most optimal buy level of the year. There have...
Healthcare has been a safe bet this past year and is starting to look weak across the board. The sector is usually defensive, but it feels overbought. Should see continued selling. Short term PT: $320
trading 50x earnings. negative earnings and rev growth. MAX short. stops 380 2x consecutive daily closes ABOVE. upside 20-30%